Crossmark

Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain

Crossref DOI link: https://doi.org/10.1016/j.reumae.2022.12.004

Published Print: 2023-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Monte-Boquet, Emilio http://orcid.org/0000-0001-5352-2601
Florez, Ángeles http://orcid.org/0000-0001-9373-7826
Alcaín Martínez, Guillermo José http://orcid.org/0000-0002-6274-6049
Sellas, Agustí http://orcid.org/0000-0003-2812-2467
License Information

Text and Data Mining valid from 2023-10-01
More Information

This article is maintained by: Elsevier

Article Title: Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2022.12.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2022.12.001

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.